In summary, GRK5-IN-2, a small molecule GRK5 inhibitor, did not mitigate diet-induced obesity or improve adipose tissue health but significantly reduced hepatic lipid accumulation. This evidence concerns the gene GRK5 and obesity due to melanocortin 4 receptor deficiency.